Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor

Clinical trial NCT06190782 · RECRUITING

Trial details

NCT number: NCT06190782
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Esophageal Squamous Cell Carcinoma Oligometastatic Disease Radiotherapy

Start date: 2022-09-27
Primary completion: 2025-09-27
Enrollment: 354

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.